SCHEMBL649353

SCHEMBL649353

CCCCn1c(-c2ccccc2)nc(Cl)c1CN(Cc1ccc2c(c1)OCCO2)c1c(C)cccc1OC(C)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.49
PTGDR2 Q9Y5Y4 4/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP2C8 P10632 1/20 0.36
HTR2A P28223 2/20 0.36
HTR2C P28335 2/20 0.36
SLC6A4 P31645 2/20 0.36
TP53 P04637 2/20 0.35
ALDH1A1 P00352 4/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPK1 P28482 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
GAA P10253 1/20 0.33
PIK3CG P48736 1/20 0.33
POLB P06746 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL650148 0.87 C5AR1 (0.48) C5AR1PTGDR2CYP2C9CYP2C19CYP2C8
SCHEMBL651031 0.86 C5AR1 (0.48) C5AR1PTGDR2CYP2C9CYP2C19CYP2C8
SCHEMBL648948 0.84 C5AR1 (0.50) C5AR1PTGDR2CYP2C9CYP2C19CYP2C8
SCHEMBL650146 0.84 C5AR1 (0.51) C5AR1PTGDR2CYP2C9CYP2C19CYP2C8
SCHEMBL651208 0.83 C5AR1 (0.49) C5AR1PTGDR2CYP2C9CYP2C19CYP2C8
SCHEMBL652376 0.81 C5AR1 (0.58) C5AR1PTGDR2CYP2C9CYP2C19CYP2C8
SCHEMBL1913082 0.81 C5AR1 (0.49) C5AR1PTGDR2CYP2C9CYP2C19CYP2C8
SCHEMBL1913084 0.81 C5AR1 (0.51) C5AR1PTGDR2CYP2C9CYP2C19CYP2C8
SCHEMBL648949 0.80 PTGDR2 (0.51) C5AR1PTGDR2CYP2C9CYP2C19CYP2C8
SCHEMBL651214 0.80 C5AR1 (0.50) C5AR1PTGDR2CYP2C9CYP2C19CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed